Kiyohara T, Kumakiri M, Kobayashi H, Shimizu T, Ohkawara A, Ohnuki M
Department of Dermatology, Fukui Medical University, Japan.
J Cutan Pathol. 2000 Sep;27(8):413-8. doi: 10.1034/j.1600-0560.2000.027008413.x.
Intravascular lymphoma is a rare disease characterized by the proliferation of neoplastic monuclear cells within the lumens of small blood vessels. The neoplastic cells are usually of B-cell origin, and rarely of T-cell or histiocytic origin. Although this clinicopathological entity of lymphoma has not been listed in general pathological classifications such as REAL classification or the Working Formulation, it is recently in the WHO classification scheme, which is essentially an updated REAL scheme, and the EORTC classification scheme.
In this report, a 62-year-old woman with intravascular large B-cell lymphoma was observed by clinical, histopathological, immunohistochemical and molecular methods.
A 62-year-old woman presented with large erythematous macules on the bilateral thighs and lower legs. The lesions were accompanied with hard, tender, intradermal or subcutaneous nodules mimicking erythema nodosum. Histopathological examination in the first biopsy revealed non-specific panniculitis compatible with erythema nodosum. The second biopsy revealed emboli of atypical lymphocytes within many of the dilated and proliferated vessels in the deep dermis and subcutaneous tissue. These cells were positive for L-26 and kappa light chain, and negative for lambda light chain, factor VIII-related antigen, CD30, CD34, CD68 and UCHL-1. These findings confirmed the diagnosis of intravascular large B-cell lymphoma. A laboratory examination showed a high level of LDH and abnormal cells in the bone marrow. An MRI of the brain and computed tomographic (CT) scans of the chest and abdomen revealed no evidence of malignancy. Before the treatment, the size of the nodules decreased spontaneously by about 50% in one month and significantly in two months. Although combination chemotherapy, which consisted of CHOP, brought her partial remission, she experienced neurological symptoms 6 months after the initial treatment and died of brain metastasis 9 months after the treatment.
This is a unique case for two following reasons: 1) the first biopsy revealed non-specific findings compatible with erythema nodosum; and 2) before the treatment, the nodules regressed spontaneously. Dermatologists should take multiple skin biopsies for EN lesions with the non-specific histopathological findings not to refute the existence of this disease.
血管内淋巴瘤是一种罕见疾病,其特征为肿瘤性单核细胞在小血管腔内增殖。肿瘤细胞通常起源于B细胞,很少起源于T细胞或组织细胞。尽管这种淋巴瘤的临床病理实体未被列入诸如REAL分类或工作方案等一般病理分类中,但最近被列入了WHO分类方案(本质上是更新后的REAL方案)和EORTC分类方案。
在本报告中,通过临床、组织病理学、免疫组织化学和分子方法对一名患有血管内大B细胞淋巴瘤的62岁女性进行了观察。
一名62岁女性双侧大腿和小腿出现大片红斑性斑疹。病变伴有坚硬、压痛的真皮内或皮下结节,类似结节性红斑。首次活检的组织病理学检查显示为与结节性红斑相符的非特异性脂膜炎。第二次活检显示真皮深层和皮下组织中许多扩张和增殖血管内有非典型淋巴细胞栓子。这些细胞L-26和κ轻链呈阳性,λ轻链、因子VIII相关抗原、CD30、CD34、CD68和UCHL-1呈阴性。这些发现证实了血管内大B细胞淋巴瘤的诊断。实验室检查显示乳酸脱氢酶水平升高且骨髓中有异常细胞。脑部MRI以及胸部和腹部计算机断层扫描(CT)未发现恶性肿瘤迹象。治疗前,结节大小在1个月内自发缩小约50%,2个月内显著缩小。尽管由CHOP组成的联合化疗使她部分缓解,但她在初始治疗6个月后出现神经症状,并在治疗9个月后死于脑转移。
这是一个独特的病例,原因如下:1)首次活检显示与结节性红斑相符的非特异性结果;2)治疗前,结节自发消退。皮肤科医生应对具有非特异性组织病理学结果的结节性红斑病变进行多次皮肤活检,以免漏诊该病。